# A Study to Compare the Effect of Giving Dulaglutide Using an Auto-injector Versus a Manual Syringe

> **NCT01524770** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 50 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **BIOLOGICAL:** Dulaglutide

## Key facts

- **NCT ID:** NCT01524770
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2014-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01524770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01524770, "A Study to Compare the Effect of Giving Dulaglutide Using an Auto-injector Versus a Manual Syringe". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01524770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*